Therapy News and Research

RSS

Got long covid? Medical expertise is vital, and seniors should prepare to go slow

Older adults who have survived covid-19 are more likely than younger patients to have persistent symptoms such as fatigue, breathlessness, muscle aches, heart palpitations, headaches, joint pain, and difficulty with memory and concentration — problems linked to long covid.

31 May 2022

New compounds for cancer immunotherapy via STING-mediated immune activation

Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment.

31 May 2022

Vitamin D therapy may be a useful addition to the treatment of ovarian cancer, study suggests

Ovarian cancer has one of the highest death rates of all cancers. One reason for this is that cancer turns the body's defenses against itself. However, new research from Nagoya University published in Matrix Biology suggests that vitamin D can effectively prevent one of the key pathways used by this cancer.

30 May 2022

Discovery explains why patients with severe asthma are unresponsive to treatment

Patients with the most severe form of asthma produce special substances in their airways when taking medicine during an asthma attack that block the treatment from working, according to a study where Rutgers scientists collaborated with researchers at Genentech, a member of the Roche Group.

30 May 2022

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

The internationally renowned pharmaceutical scientist Professor Hans Lennernäs of Uppsala University has been given a Humboldt Research Award worth EUR 60,000 by the Alexander von Humboldt Foundation.

30 May 2022

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Two recently published studies by UW Medicine researchers indicate that clinicians should offer non-pharmaceutical help for pain, fatigue, depression, or anxiety at the time of diagnosis for patients with multiple sclerosis, rather than wait.

30 May 2022

Specially trained therapy dog expands the world for autistic children

A new Australian study looking at the impact of an autism assistance dog for children and their parents has made an unexpected discovery: the dog has expanded their world, literally.

30 May 2022

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.

30 May 2022

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality.

30 May 2022

Researchers evaluate atovaquone as a COVID-19 treatment

Researchers evaluated a drug, atovaquone, for COVID-19 treatment.

30 May 2022

Interactive web portal details the extent of splicing events in noncoding sequences

An online tool reveals the extent of gene-restructuring events in noncoding sequences.

30 May 2022

Researchers investigate gestational diabetes mellitus and its association with maternal and fetal outcomes

Researchers quantify the outcomes of pregnancies complicated by gestational diabetes.

30 May 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

Study finds TGF-β2 associated with asymptomatic mild SARS-CoV-2 infection during pregnancy

A new study investigated the clinical and obstetric outcomes after SARS-CoV-2 infection in two groups of pregnant women, along with their association with the immunological parameters.

28 May 2022

Discovery of new prostate cancer subtype opens the door to development of therapies

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.

27 May 2022

Understanding transposons provides a new starting point to generate more powerful gene editing tools

CRISPR has ushered in the era of genomic medicine. A line of powerful tools has been developed from the popular CRISPR-Cas9 to cure genetic diseases.

27 May 2022

Diabetes drug can improve the efficiency and efficacy of antibacterial treatments

Old dogs may not learn new tricks, but old drugs can, according to a research team based in China. The collaboration found that Metformin, a small molecule drug that has been used to treat type II diabetes for more than 50 years, can improve the efficiency and efficacy of antibacterial treatments for quick wound-healing in mice.

27 May 2022

2-Deoxy-D-glucose may inhibit coronaviruses and rhinoviruses

Scientists demonstrated the use of 2-deoxy-D-glucose (2-DG) as a wide-spectrum antiviral agent targeting viruses such as SARS-CoV-2.

27 May 2022

New approach could treat brain tumors and also prevent or delay recurrences

Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small molecule that blocked a key pathway in brain tumors.

27 May 2022

Researchers develop a bioresorbable pacemaker to temporarily monitor and control heart rate

In a proof-of-concept study that aims to address the unmet need for minimally invasive cardiac control and monitoring devices, researchers have developed a network of wireless devices, including a bioresorbable pacemaker, that can temporarily monitor and control heart rate.

27 May 2022

Therapy News and Research

Got long covid? Medical expertise is vital, and seniors should prepare to go slow

New compounds for cancer immunotherapy via STING-mediated immune activation

Vitamin D therapy may be a useful addition to the treatment of ovarian cancer, study suggests

Discovery explains why patients with severe asthma are unresponsive to treatment

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Specially trained therapy dog expands the world for autistic children

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Researchers evaluate atovaquone as a COVID-19 treatment

Interactive web portal details the extent of splicing events in noncoding sequences

Researchers investigate gestational diabetes mellitus and its association with maternal and fetal outcomes

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

Study finds TGF-β2 associated with asymptomatic mild SARS-CoV-2 infection during pregnancy

Discovery of new prostate cancer subtype opens the door to development of therapies

Understanding transposons provides a new starting point to generate more powerful gene editing tools

Diabetes drug can improve the efficiency and efficacy of antibacterial treatments

2-Deoxy-D-glucose may inhibit coronaviruses and rhinoviruses

New approach could treat brain tumors and also prevent or delay recurrences

Researchers develop a bioresorbable pacemaker to temporarily monitor and control heart rate

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News